Sumitomo Pharma Co.,Ltd. [4506.T]
TOKYO, Apr 27 (Pulse News Wire) – Sumitomo Pharma CO.,LTD. (4506.T) withdrew its share issuance registration today, following a successful offering completed earlier this month.
The withdrawal pertains to a registration filed on March 2, 2026, which was initially set to expire on March 10, 2027. The registration aimed to issue up to 148,900,000 ordinary shares, but the company conducted an offering totaling ¥148.90 million in aggregate value. Additionally, the company raised an additional ¥208.30 million through offerings in overseas markets, excluding sales to qualified institutional buyers in the United States under Rule 144A of the U.S. Securities Act. The decision to withdraw the registration was due to the completion of the planned share issuance. However, there remains a possibility of further share issuance related to an over-allotment allocation to SMBC Nikko Securities Co., Ltd., capped at ¥208.40 million, scheduled for May 26, 2026.
Details of this potential issuance can be found in previous disclosures dated March 10, 2026, and April 20, 2026. This notice is intended solely for public dissemination regarding the withdrawal of the share issuance registration and does not constitute investment advice or solicitation within Japan or internationally. Sumitomo Pharma has not registered its ordinary shares under the U.S. Securities Act of 1933 and has no plans to do so. Therefore, any securities offerings or sales in the U.S. would require either registration under the act or reliance on an exemption from such registration requirements.
🟢 Confidence: High AI-translated content.